Royalty Pharma’s Acquisition of Royalty Interest in TRELEGY ELLIPTA

Martina Bellini
Tagged:

Goodwin advised Royalty Pharma plc on the deal.Royalty Pharma plc (Nasdaq: RPRX) announced its definitive agreement to acquire a royalty interest in TRELEGY ELLIPTA (Trelegy) from Theravance…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now